Search
News & Events
Community partnership sets priorities for preterm lung health researchRespiratory disease remains one of the most significant complications of preterm birth, with lasting consequences.
Research
SHIP CT: A Phase 3 randomised, double-blind, controlled trial of inhaled 7% hypertonic saline versus 0.9% isotonic saline for 48 weeks in patients with Cystic Fibrosis at 3-6 years of age in parallel with the North American SHIP clinical trial.SHIP-CT, led by Professor Stephen Stick, Director of the Wal-yan Respiratory Research Centre at The Kids, is a unique study in preschool-aged children (from 3-6 years of age) with CF using images of the lung from chest CT scans as the main outcome measure.
Research
CybersafetyEven in the safety of their home, there are many risky places a child or teenager can visit online. This can be due to the content they see, who they come into contact with, and personal information they share.
News & Events
Parents’ top tips for managing their kids’ device useHave you ever wondered how other parents manage their kids’ device use? As part of a survey for our Cyber Savvy Project, The Kids researchers asked a group of parents for their top tips regarding their child's use of devices.
News & Events
Setting smart phone rulesMobile phones are an important part of diabetes management but its also important to set some family rules for your child's technology use.
We rely on the support of donors & fundraisers to be able to conduct the life changing pediatric research we do on a day-to-day basis. Will you help?
An outline of ORIGINS sub-projects by name
Investigating school readiness in ORIGINS' five-year-olds
News & Events
Healthy lunch ideas for kids during COVID-19All parents are familiar with the nightly battle to get the kids to eat their vegies, but did you know primary-school aged children get over one third of their energy intake from the food they consume during school hours
News & Events
Therapy for babies with signs of autism cuts long-term disability costsNew research evaluating the potential cost savings of a therapy for babies displaying early autism signs has predicted a three dollar return to Australia’s National Disability Insurance Scheme (NDIS) for every dollar invested in therapy.